IMS reported revenue for the twelve months ended December 31, 2014 increased 5.9 percent on a constant currency basis compared with last year. On a reported basis, revenue increased 3.8 percent to $2,641 million. Adjusted EBITDA of $878 million increased 9.5 percent on a constant currency basis, or 5.9 percent reported compared with 2013. The 2014 net loss was $189 million, compared with net income of $82 million in 2013, with the decline due to one-time IPO-related charges. Adjusted Net Income was $454 million, up 24 percent on a constant currency basis or 18 percent on a reported basis. The full-year diluted loss per share was $0.59 compared with diluted earnings per share of $0.29 for 2013. Adjusted Diluted Earnings per Share was $1.37 for 2014, up three cents from 2013.
Revenue for the fourth quarter increased 6.2 percent on a constant currency basis, or 0.6 percent on a reported basis, to $678 million, compared with the fourth quarter of 2013. The company’s strong revenue performance in the fourth quarter was driven by a 13.6 percent increase in technology services revenue on a constant currency basis, or 8.8 percent on a reported basis. Information offerings revenue was up 0.8 percent on a constant currency basis, or down 5.5 percent on a reported basis. Revenue grew across all regions at constant currency. Emerging markets revenue increased 9.7 percent on a constant currency basis, decreasing 1.0 percent on a reported basis. Developed markets revenue grew 5.5 percent on a constant currency basis, or up 0.9 percent reported, versus the same period last year.
Adjusted EBITDA improved 8.5 percent on a constant currency basis, or 1.1 percent reported, to $214 million, compared with the fourth quarter of 2013. This reflected both the drop-through from revenue growth to Adjusted EBITDA and the impact of continued cost-reduction initiatives. Adjusted EBITDA as a percentage of revenue for the quarter improved by 68 basis points on a constant currency basis, or 18 basis points on a reported basis, to 31.6 percent.
Fourth-quarter 2014 net income was $8 million, compared with $82 million in last year’s fourth quarter. Adjusted Net Income was $125 million, up $46 million from the prior-year’s quarter due to lower interest expense.
Diluted earnings per share was $0.03 in the fourth quarter, compared with $0.29 per share in the fourth quarter of 2013. Adjusted Diluted Earnings per Share was $0.36 in the fourth quarter, compared with $0.28 in the prior-year period, a 40 percent increase on a constant currency basis and 31 percent on a reported basis.
Reported results for the quarter were tempered by the continued strengthening of the U.S. dollar against key foreign currencies and the lower U.S. dollar results from the company’s Venezuelan operations due to the significant revaluation of the Venezuelan Bolivar effective June 30, 2014.
2015 Full-Year Guidance
We expect Core IMS Health (excluding the impact of the pending acquisition of Cegedim’s CRM and Strategic Data businesses) to have full-year 2015 constant currency growth of 5 to 6 percent in revenue, 7.5 to 8.5 percent in Adjusted EBITDA, 16 to 19 percent in Adjusted Net Income, and 11 to 14 percent in Adjusted Diluted Earnings per Share. Including the acquisition of Cegedim’s CRM and Strategic Data businesses, which we anticipate will close in April, we expect IMS Health to have full-year 2015 constant currency growth of 19 to 20 percent in revenue, 13 to 14 percent in Adjusted EBITDA, 20 to 23 percent in Adjusted Net Income, and 15 to 18 percent in Adjusted Diluted Earnings per Share; on a reported basis, and assuming current foreign exchange rates hold constant through the end of the year, these growth rates would be 11 to 12 percent for revenue, 5 to 6 percent for Adjusted EBITDA, 8 to 11 percent for Adjusted Net Income, and 4 to 6 percent for Adjusted Diluted Earnings per Share.
Source: IMS Earnings Release






